nontuberous mycobacterial lung disease

Phase 3 Data For Nontuberculous Lung Disease Trial Has Been Published

Post author:James Moore
Post published:September 18, 2018
Post category:Bronchiectasis Cystic Fibrosis Nontuberculous Mycobacteria Lung Disease Rare Disease

According to a story from pm360online.com, the biopharmaceutical company Insmed Incorporated recently announced that the data from its Phase 3 clinical trial of amikacin liposome inhalation suspension (ALIS). ALIS was…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More